United States (US) Chronic Hepatitis B (CHB) Market (2025-2031) | Competitive Landscape, Growth, Trends, Segmentation, Companies, Size & Revenue, Value, Forecast, Share, Outlook, Analysis, Industry

Name: United States (US) Chronic Hepatitis B (CHB) Market (2025-2031) | Competitive Landscape & Growth
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Class (Antivirals, Immune Modulators), By Gender (Male, Female), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers) And Competitive Landscape

Product Code: ETC9962420	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Chronic Hepatitis B (CHB) Market Outlook
Market Size of United States (US) Chronic Hepatitis B (CHB) Market, 2024
Forecast of United States (US) Chronic Hepatitis B (CHB) Market, 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Revenues & Volume for the Period 2021- 2031
United States (US) Chronic Hepatitis B (CHB) Market Trend Evolution
United States (US) Chronic Hepatitis B (CHB) Market Drivers and Challenges
United States (US) Chronic Hepatitis B (CHB) Price Trends
United States (US) Chronic Hepatitis B (CHB) Porter's Five Forces
United States (US) Chronic Hepatitis B (CHB) Industry Life Cycle
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Antivirals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Immune Modulators for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Gender for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Male for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Female for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Drug Stores and Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume By Online Providers for the Period 2021- 2031
United States (US) Chronic Hepatitis B (CHB) Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Gender
Market Opportunity Assessment By Distribution Channel
United States (US) Chronic Hepatitis B (CHB) Top Companies Market Share
United States (US) Chronic Hepatitis B (CHB) Competitive Benchmarking By Technical and Operational Parameters
United States (US) Chronic Hepatitis B (CHB) Company Profiles
United States (US) Chronic Hepatitis B (CHB) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Chronic Hepatitis B (CHB) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Chronic Hepatitis B (CHB) Market - Industry Life Cycle

3.4 United States (US) Chronic Hepatitis B (CHB) Market - Porter's Five Forces

3.5 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Gender, 2021 & 2031F

3.7 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Chronic Hepatitis B (CHB) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic hepatitis B in the United States

4.2.2 Advancements in treatment options for chronic hepatitis B

4.2.3 Growing awareness and screening programs for hepatitis B

4.3 Market Restraints

4.3.1 High cost of treatment for chronic hepatitis B

4.3.2 Limited access to healthcare services for some populations

4.3.3 Potential side effects and risks associated with current treatment options

5 United States (US) Chronic Hepatitis B (CHB) Market Trends

6 United States (US) Chronic Hepatitis B (CHB) Market, By Types

6.1 United States (US) Chronic Hepatitis B (CHB) Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Antivirals, 2021- 2031F

6.1.4 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Immune Modulators, 2021- 2031F

6.2 United States (US) Chronic Hepatitis B (CHB) Market, By Gender

6.2.1 Overview and Analysis

6.2.2 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Male, 2021- 2031F

6.2.3 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Female, 2021- 2031F

6.3 United States (US) Chronic Hepatitis B (CHB) Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F

6.3.4 United States (US) Chronic Hepatitis B (CHB) Market Revenues & Volume, By Online Providers, 2021- 2031F

7 United States (US) Chronic Hepatitis B (CHB) Market Import-Export Trade Statistics

7.1 United States (US) Chronic Hepatitis B (CHB) Market Export to Major Countries

7.2 United States (US) Chronic Hepatitis B (CHB) Market Imports from Major Countries

8 United States (US) Chronic Hepatitis B (CHB) Market Key Performance Indicators

8.1 Number of individuals screened for chronic hepatitis B annually

8.2 Rate of diagnosis and linkage to care for chronic hepatitis B patients

8.3 Adoption rate of new treatment guidelines for chronic hepatitis B

9 United States (US) Chronic Hepatitis B (CHB) Market - Opportunity Assessment

9.1 United States (US) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Gender, 2021 & 2031F

9.3 United States (US) Chronic Hepatitis B (CHB) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Chronic Hepatitis B (CHB) Market - Competitive Landscape

10.1 United States (US) Chronic Hepatitis B (CHB) Market Revenue Share, By Companies, 2024

10.2 United States (US) Chronic Hepatitis B (CHB) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Estonia Chronic Hepatitis B (CHB) Market

Ethiopia Chronic Hepatitis B (CHB) Market

Fiji Chronic Hepatitis B (CHB) Market

Finland Chronic Hepatitis B (CHB) Market

Gabon Chronic Hepatitis B (CHB) Market

Global Chronic Hepatitis B (CHB) Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here